Switch to anti-programmed cell death protein 1 (anti-PD-1) fixed-dose regimen: What is the economic impact?

Title
Switch to anti-programmed cell death protein 1 (anti-PD-1) fixed-dose regimen: What is the economic impact?
Authors
Keywords
Immunotherapy, Anti–PD-1/PD-L1, Fixed-dose regimens, Budget impact
Journal
EUROPEAN JOURNAL OF CANCER
Volume 113, Issue -, Pages 28-31
Publisher
Elsevier BV
Online
2019-04-06
DOI
10.1016/j.ejca.2019.02.016

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More